Skip to main content
SubPopulations and InteRmediate Outcome Measures In COPD Study
Manuscripts and Publications
Search
Show only items where
Author
any
Aaron, Carrie P
Alexis, Neil E
Amanda, Gassett
Ampleford, Elizabeth J
An, Steven S
Anderson, Wayne H
Anderson, Wayne
Artigas, María Soler
Austin, John H M
Azar, Antoine
Badr, Safwan
Baglole, Carolyn J
Bailey, William
Bakke, Per
Barjaktarevic, Igor Z
Barjaktarevic, Igor
Barr, Graham
Barr, Graham
Barr, R G
Bartz, Traci M
Basner, Robert C
Basta, Patricia V
Beaty, Terri H
Beaty, Terri
Belinsky, Steven A
Belli, Andrew J
Bhakta, Nirav
Bhatt, Surya P
Blanc, Paul D
Bleecker, Eugene
Bleecker, Eugene R
Bodduluri, Sandeep
Boes, Jennifer L
Boezen, Marike
Bonser, Luke R
Bossé, Yohan
Boucher, Richard C
Bowler, Russell P
Bowler, Russell
Bowler, Russ P
Bradford, Eric
Brown, Jeanette P
Brune, Kieran A
Brusselle, Guy G
Bule, Maria
Burkes, Robert M
Burnette, Nathan
Cao, Rui
Cardoso, Wellington V
Carretta, Elizabeth E
Casaburi, Richard
Cascio, Christian M Lo
Castaldi, Peter
Castaldi, Peter J
Ceppe, Agathe
Ceppe, Agathe S
Chamberlain, Ryan
Chan, Kung-Sik
Chase, Robert P
Chen, Ting-Huei
Cho, Michael
Cho, Michael H
Choi, Justin C
Choi, Jiwoong
Choi, Sanghun
Christenson, Stephanie
Christenson, Stephanie A
Cigolle, Christine T
Comellas, Alejandro P
Comellas, Alejandro
Cooper, Christopher B
Cooper, Christopher
Cooper, Chris
COPDGene and SPIROMICS Investigators
COPDGene and SPIROMICS Investigators ‡
COPDGene Investigators
Corry, David B
Couper, David J
Couper, David
Crapo, James D
Crapo, James
Criner, Gerard J
Criner, Gerard
Cristenson, Stephanie
Crudgington, Sean
Current and former investigators of the SPIROMICS sites and reading centers
Curtis, Jeffrey L
Dashnaw, Stephen M
Davis, William
Davis, Sonia M
de Jong, Kim
de Koning, Harry J
De Stefano, Frank
Demeo, Dawn
DeMeo, Dawn L
Deshmane, Swati P
Deshmukh, Rahul
Diaz, Alejandro A
Diette, Gregory B
Doerschuk, Claire M
Donohue, Kathleen M
Dransfield, Mark T
Drummond, Bradley
Drummond, Brad
Dupuis, Josée
ECLIPSE Investigators
Eisner, Mark D
Ejike, Chinedu
Erle, David J
Faiz, Alen
Fan, Vincent
Fawzy, Ashraf
Fernández-Baldera, Antonio
Fingerlin, Tasha E
for COPDGene and SPIROMICS Investigators
Ford, Amina A
Foreman, Marilyn G
Foreman, Marilyn
Franceschini, Nora
Freeman, Christine M
Gaggar, Amit
Galbán, Craig J
Garudadri, Suresh
Gassett, Amanda J
Gharib, Sina A
Ghosh, Sohini
Goldin, Jonathan
Gouskova, Natalia A
greenberg, jane
Groen, H J
Gu, Tian
Gu, Bon-Hee
Gulsvik, Amund
Guo, Xiuqing
Guo, Jia
Guo, Junfeng
Ha, Jae Wook
Haghighi, Babak
Hall, Ian P
Hammond, Emily
Han, Meilan K
Han, MeiLan
Han, Mei Lan
Han, Mei Lan K
Hanania, Nicola A
Hansel, Nadia N
Hardin, Megan
Harrington, Kathleen F
Hastie, Annette T
Hatt, Charles R
Hawkins, Gregory A
Hawrylkiewicz, Iwona
Heckbert, Susan R
Henderson, Ashley G
Hersh, Craig P
Hersh, Craig
Hiemstra, Pieter S
Hirzel, Andrew J
Hobbs, Brian D
Hoff, Benjamin A
Hoffman, Eric A
Hogue, Shayna
Hokanson, John E
Holm, Kristen E
Hoth, Karin F
Hughes, Emlyn W
Iii, Robert Paine
Inkamp, Kai
International COPD Genetics Consortium
International COPD Genetics Network Investigators
Investigators, The Spiromics
Jackson, Victoria E
Jacobs, David R
Jacobson, Sean
Jin, Dakai
Johnson, Timothy D
Kaner, Robert J
Kanner, Richard E
Kanner, Richard
Kaufman, Joel
Kaufman, Joel D
Kazerooni, Ella A
Kazerooni, Ella
Kechris, Katerina
Keene, Jason D
Kesimer, Mehmet
Kheradmand, Farrah
Kim, Woo Jin
Kim, Deog Kyeom
Kim, Young-Il
Kim, Victor
Kinney, Gregory L
Kleerup, Eric
Kleerup, Eric A C
Kleerup, Eric C
Koch, Abby
Koth, Laura
Krachman, Samuel
Krishnan, Jerry A
Krishnanm, Jerry A
Labaki, Wassim W
Lahousse, Lies
Lam, Hong
Lambert, Allison A
Lammers, Jan W
Lamontagne, Maxime
Latourelle, Jeanne C
LaVange, Lisa M
Lazarus, Stephen C
Lee, Mi Kyeong
Leidy, Nancy K
LeMaire, Scott A
Leng, Shuguang
Li, Xingnan
Li, Sara X
LifeLines Investigators
Lin, Ching-Long
Lina, Huang
Litonjua, Augusto A
Liu, Kiang
Locantore, Nicholas
Lomas, David A
London, Stephanie J
Luong, Amber
Lutz, Sharon
Lynch, David A
MacNee, William
Make, Barry
Make, Barry J
Mandke, Pooja
Manichaikul, Ani
Manichaikul, Ani W
Marchetti, Nathaniel
Martin, Jennifer L
Martinez, Fernando
Martinez, Carlos H
Martinez, Carlos
Martinez, Fernando J
Meldrum, Catherine
MESA Lung and SPIROMICS investigators
Meyers, Deborah A
Miller, Bruce E
Mitchell, Michael N
Mostafa, Javed
Murray, Susan
Nath, Hrudaya P
Newell, John D
Nguyen, Jennifer N
NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)
Nishida, Kristine
North, Kari E
O'Connor, George T
O'Neal, Wanda K
O'Neal, Wanda
Oelsner, Elizabeth C
Oh, Yeon-Mok
Ortega, Victor E
Oster, Robert A
Oudkerk, Matthijs
Paine, Robert
Paine, Richard
Paré, Peter D
Parker, Margaret M
Parulekar, Amit D
Patrick, Breysse
Paul, Gabriel G
Paulin, Laura M
Peters, Stephen
Peters, Stephen P
Pirozzi, Cheryl S
Pirozzi, Cheryl
Pirozzi, Cheryl B
Postma, Dirkje S
Prince, Martin R
Psaty, Bruce M
Puhan, Milo A
Putcha, Nirupama
Qiao, Dandi
Quibrera, Pedro M
Quibrera, Pedro Miguel
Rabinowitz, Dan
Radicioni, Giorgia
Ramachandran, Rekha
Ramsdell, Joe
Regan, Elizabeth A
Rehemtulla, Alnawaz
Rennard, Stephen I
Rennard, Stephen
Rich, Stephen S
Robinson, Douglas N
Rodriguez, Antony
Roger, Peng
Ross, Brian D
Rotter, Jerome I
Rous, Jennifer
Saha, Punam K
Saylor, Melissa
Scheurer, Michael E
Schneider, Hartmut
Scholand, Mary Beth
Schotland, Helena
Schwartz, David A
Shade, Danny
Shen, Ying H
Shimbo, Daichi
Shrine, Nick
Sidhaye, Venkataramana K
Sieren, Jessica C
Sieren, Jered P
Sieren, Alexa
Silverman, Edwin K
Simon, Leora
Sliwinski, Pawel
Sloan, Chelsea
Smith, Benjamin M
Sonavane, Sushil
Song, Li-Zhen
Sonstein, Joanne
Sparrow, David
Spira, Avrum
SPIROMICS and COPDGene Investigators
SPIROMICS Investigative Group
SPIROMICS Investigators
SPIROMICS Research Group
Srivastava, Vasudha
Stolberg, Valerie R
Strachan, David P
Stricker, Bruno H
Subpopulations and Intermediate Outcome Measures in COPD Study Investigators
Sun, Yanping
Sun, Wei
Sundar, Krishna
Tal-Singer, Ruth
Tashkin, Donald
Tashkin, Donald P
Taylor, Kent D
Tayob, Nabihah
Terry, Nina L J
Tesfaigzi, Yohannes
Timens, Wim
Tobin, Martin D
Traboulsi, Hussein
Uitterlinden, André G
UK BiLEVE Investigators
van den Berge, Maarten
Varasteh, Jason
Vestbo, Jørgen
Vidal, Craig
Vonk, Judith M
Wain, Louise V
Wang, Xin-Qun
Wang, Chao
Wang, Menghan
Watson, Karol E
Watts, Jubal R
Wedzicha, Jadwiga A
Wells, Michael
Wells, Michael
Wilk, Jemma B
Wise, Robert A
Wise, Robert
Woodruff, Prescott
Woodruff, Prescott G
Wyss, Annah B
Xia, Meng
Yang, Jenny
Yim, Jae-Joon
Zanen, Pieter
Zeidler, Michelle R
Zeidler, Michelle
Zlock, Lorna T
Type
any
Manuscript
Publication
Term
any
-
Ancillary Studies - 008 Airway mucus/mucin composition, structure and proteome in COPD: A SPIROMICS ancillary study (M. Kesimer)
Ancillary Studies - 013 PGP, A Possible Biomarker for COPD Exacerbations and or Progression (J. Blalock)
Ancillary Studies - 017 Common genomic mechanisms of disease across asthma and COPD (S. Christenson)
Ancillary Studies - 019 Validation study for lung cell gene expression (R. Kaner)
Ancillary Studies - 023 Discovery of Quantitative Emphysema Subtypes on CT Scans (G. Barr)
Ancillary Studies - 025 Imaging Predictors of Disease Progression in COPD (M. Han/E. Hoffman)
Ancillary Studies - 026 SPIROMICS Air Pollution Study (N. Hansel)
Ancillary Studies - 029 Parametric Response Mapping in COPD (M. Han/F. Martinez)
Ancillary Studies - 030 Understanding the allergic phenotype of COPD and its association with clinical outcomes (N. Putucha)
Ancillary Studies - 032 Identifying the Th2 endotype in COPD: clinical and pathologic implications (S. Christenson)
Ancillary Studies - 035 Synergistic Effects of Serum CC16 and Inflammatory Biomarkers on COPD Outcomes (S. Guerra)
Ancillary Studies - 038 Cathelicidin and Vitamin D: Impact on Populations At-Risk and with COPD (B. Drummond)
Ancillary Studies - 039 Qualitative Mucus Phenotyping in Chronic Bronchitis (E. Neptune)
Ancillary Studies - 040 Mechanisms of telomere-induced emphysema (M. Armanios/ N.Hansel)
Ancillary Studies - 043 Mitophagy and/or necroptosis factors as biomarkers of disease severity and activity in COPD. (A. Choi)
Ancillary Studies - 045 The Role of PGP in COPD-associated Pulmonary Hypertension (Project Extension of J .Edwin Blalock’s SPIROMICS Ancillary Study - 1R01HL114439) (Wells)
Ancillary Studies - 048 Th2-associated blood biomarkers in COPD (Woodruff)
Ancillary Studies - 049 Sphingolipids biomarkers of COPD progression in healthy smokers (Bowler)
Ancillary Studies - 050 Compartmental Analysis of Metabolite Profiles associated with Disease Phenotypes in Chinese and US Smokers with and without COPD (Han)
Ancillary Studies - 051 The Effect of Rare SERPINA1 Variants on α-1AT levels and COPD-related Phenotypes (Ortega)
Ancillary Studies - 052 Pathologic, Inflammatory, and Genomic Correlates of Chronic Bronchitis (Kim/Christenson)
Ancillary Studies - 054 Emphysema and cardiovascular disease: Role of systemic inflammation (Bhatt)
Ancillary Studies - 057 Nucleotides and COPD: ectoenzyme activity regulates ATP levels (Lazarowski)
Ancillary Studies - 058 Predictive value of BAL sRAGE and sICAM-1 in COPD (Paine)
Ancillary Studies - 059 The Effect of Known and Novel Rare SERPINA1 Variants on α-1AT levels and COPDrelated Phenotypes in a Multi-Ethnic COPD Cohort (Ortega)
Ancillary Studies - 061 Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD ( Manichaikul)
Ancillary Studies - 065 Iron-related pathways (iron, lipocalin2 and hepcidin) as biomarkers for defining clinical sub-types in COPD (Cloonan)
Ancillary Studies - 070 Radiology Reads to Measure Visual Features from HRCT in SPIROMICS (Newell)
Ancillary Studies - 074 Plasma proteomic profiles in SPIROMICS bronchoscopy subjects (Bowler)
Ancillary Studies - 075 The bacterial microbiome in sputum in the SPIROMICS cohort. (Bowler)
Ancillary Studies - 080 : SOMAScan Assay Biomarker Discovery Grant Program (O'Neal)
Ancillary Studies - 082 Expiratory Central Airway Collapse (ECAC): Characteristics, Genetics and Progression (Bhatt)
Ancillary Studies - 084 Airway Variant Phenotyping in SPIROMICS
Ancillary Studies - 086 SPIROMICS GIC U24
Ancillary Studies - 088 Airway measures of mucin hydration
Ancillary Studies - 099 Immune function and risk for COPD and poor outcomes in SPIROMICS (Putcha)
Ancillary Studies - No Ancillary Study - SPIROMICS Core
Sites - Clinical Center: Baltimore (Johns Hopkins University)
Sites - Clinical Center: Birmingham (University of Alabama at Birmingham)
Sites - Clinical Center: Denver (National Jewish Health)
Sites - Clinical Center: Iowa (University of Iowa)
Sites - Clinical Center: Los Angeles (University of California at Los Angeles)
Sites - Clinical Center: Michigan (University of Michigan)
Sites - Clinical Center: New York (Columbia University)
Sites - Clinical Center: Pennsylvania (Temple University)
Sites - Clinical Center: San Francisco (University of California at San Francisco)
Sites - Clinical Center: Tucson (University of Arizona)
Sites - Clinical Center: Utah (University of Utah)
Sites - Clinical Center: Winston-Salem (Wake Forest University Health Sciences)
Sites - Genomics and Informatics Center (University of North Carolina at Chapel Hill)
Sites - Reading Center: Radiology (University of Iowa)
Sites - Steering Committee Chair (University of Nebraska)
Sites - Weill Cornell Medical Center
Sites for Manuscript - Clinical Center: Baltimore (Johns Hopkins University)
Sites for Manuscript - Clinical Center: Birmingham (University of Alabama at Birmingham)
Sites for Manuscript - Clinical Center: Denver (National Jewish Health)
Sites for Manuscript - Clinical Center: Michigan (University of Michigan)
Sites for Manuscript - Clinical Center: New York (Columbia University)
Sites for Manuscript - Clinical Center: San Francisco (University of California at San Francisco)
Sites for Manuscript - Clinical Center: Utah (University of Utah)
Sites for Manuscript - Clinical Center: Weill Cornell Medical Center
Sites for Manuscript - Clinical Center: Winston-Salem (Wake Forest University Health Sciences)
Sites for Manuscript - Genomics and Informatics Center (University of North Carolina at Chapel Hill)
Sites for Manuscript - Reading Center: Radiology (University of Iowa)
Status for Abstracts/Presentations/Publications - Analysis ongoing
Status for Abstracts/Presentations/Publications - Analysis pending
Status for Abstracts/Presentations/Publications - Approved by NIH
Status for Abstracts/Presentations/Publications - Draft MS Approved by Pubs in NIH Review
Status for Abstracts/Presentations/Publications - Draft MS in Pubs Review
Status for Abstracts/Presentations/Publications - Draft MS with Co-Authors
Status for Abstracts/Presentations/Publications - In Journal Review
Status for Abstracts/Presentations/Publications - In press
Status for Abstracts/Presentations/Publications - Journal Submission Pending
Status for Abstracts/Presentations/Publications - Pending resubmission to another Journal
Status for Abstracts/Presentations/Publications - Published
Status for Abstracts/Presentations/Publications - Published and Public
Status for Abstracts/Presentations/Publications - Resubmitted to Another Journal
Status for Abstracts/Presentations/Publications - Revising Draft MS after Pubs Review
Status for Abstracts/Presentations/Publications - Withdrawn
Status for Analysis - Complete
Status for Analysis - In Progress
Status for Analysis - Pending
Status for Analysis - Sufficient To Write
Status for Journals - Accepted w Revision
Status for Journals - Accepted w/o Revision
Status for Journals - Re-submission
Status for Journals - Rejected
Status for Manuscript Proposals - Approved
Status for Pubs Comm Decision - Revisions Requested
Year
any
Submitted
2019
2018
2017
2016
2015
2014
2010
0
Keyword
any
ABO Blood-Group System
ACTIVITY
Acute Disease
Adherens Junctions
Adrenal Cortex Hormones
Adult
African American
age
Age Factors
Aged
Aged, 80 and over
Aging
Air
airway disease
airway obstruction
Algorithms
Alleles
alpha 1-Antitrypsin
alpha1-antitrypsin
Alveolar macrophages
Analysis of Variance
Ancestry
anemia
Anxiety
Area Under Curve
asthma
Atherosclerosis
biomarker
biomarkers
Biomechanical Phenomena
blood analytes
blood biomarkers
Blood Cell Count
Blood Proteins
bmi
Body Mass Index
Bronchi
Bronchitis
Bronchitis, Chronic
Bronchoalveolar Lavage Fluid
Bronchodilator Agents
bronchodilator responsiveness
Cadherins
CAT
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Adhesion
Cell Death
Cell Membrane Permeability
Cell Separation
cell-cell adhesion
Chemokines
Chronic bronchitis
Chronic Obstruction Pulmonary Disease (COPD)
chronic obstructive pulmonary disease
Cigarette Smoking
cluster analysis
coefficient of variation
Cohort Studies
comorbidities
Comorbidity
Confounding Factors (Epidemiology)
COPD
COPD exacerbation
COPDGene
Coronary Artery Disease
Cost of Illness
Cross-Sectional Studies
CT
CT protocol
Cytokines
Cytoskeleton
cytotoxic lymphocytes emphysema
Data Interpretation, Statistical
Dendritic Cells
Depression
Diagnostic Techniques, Respiratory System
Disease Management
Disease Progression
Disease Susceptibility
DYSPNEA
E-Cadherin
Edetic Acid
Effect Modifier, Epidemiologic
Electronic Nicotine Delivery Systems
emphysema
endotype
Eosinophils
Epithelial Cells
Ethnic Groups
European Continental Ancestry Group
exacerbation
Exacerbations
EXERCISE
Exercise Test
Exercise Tolerance
Factor and Cluster Analyses
FATIGUE
Fc receptors; Complement receptors
Female
FEV1/FVC
Fibroblast Growth Factor 10
Flow Cytometry
Follow-Up Studies
Forced Expiratory Volume
Gastroesophageal Reflux
Genetic Loci
Genetic Predisposition to Disease
genetics
Genome-Wide Association Study
Genotype
GOLD Classification
Harm Reduction
health status
Health Status Indicators
hospitalization
Humans
IL6 trans-signaling
Image Processing, Computer-Assisted
imaging
Immunoglobulin A
Immunophenotyping
Incidence
Inflammation Mediators
inflammatory and immune cells and mediators
Interleukin 6
Interleukin 6 Receptor
Interleukin-15
Interleukin-8
interstitial lung abnormality
Leukocyte Count
Leukocytes
Logistic Models
Longitudinal Assessment
Longitudinal Studies
Lung
Lung Diseases
lung function
Lung Volume Measurements
Macrophages
Male
Mass Spectrometry
Middle Aged
mMMRC
Models, Anatomic
Monocytes
Mucin 5AC
Mucin-5B
Mucins
Multicenter Studies as Topic
Multidetector Computed Tomography
Multivariate Analysis
Myosin Type II
Natriuretic Peptide, Brain
Neutrophils
NK cells
Occupational Exposure
ontological engineering
ontology
Outcome Assessment (Health Care)
packyears
Patient Outcome Assessment
Pattern Recognition, Automated
Peptide Fragments
Phantoms, Imaging
phenotype
Phenotypes
Plasma
Polymorphism, Single Nucleotide
pQTL
Predictive Value of Tests
Prevalence
Prognosis
Proportional Hazards Models
Prospective Studies
Protease Inhibitors
Pulmonary Arteries
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Pulmonary Fibrosis
Quality Control
quality of life
Quantitative Computed Tomography
Quantitative CT
Quantitative Trait Loci
race/ethnicity
Radiographic Image Enhancement
Radiographic Image Interpretation, Computer-Assisted
radiology
rare variants
Regression Analysis
reliability
repeatability
repeatability substudy
replication substudy
Reproducibility of Results
Research Design
Respiration
Respiratory Function Tests
Respiratory System
Retrospective Studies
Risk
Risk Assessment
Risk Factors
ROC Curve
Sample Size
secondhand smoke
Sensitivity and Specificity
serum
Severity
Severity of Illness Index
Sleep
Sleep Apnea, Obstructive
Sleep Wake Disorders
Smokers
smoking
Smoking Cessation
SNPs
Spirometry
SPIROMICS
Sputum
sputum collection protocol
Subtraction Technique
Surveys and Questionnaires
Symptom Assessment
Thrombocytosis
Time Factors
Tobacco Use Disorder
Tomography, X-Ray Computed
Trachea
Treatment Outcome
United States
Vaping
Vascular Calcification
viscoelastic properties
Vital Capacity
Water
Author
Title
Type
Year
Filters:
Keyword
is
Lung Diseases
[Clear All Filters]
2016
Sieren JP
,
Newell JD
,
R Barr G
,
Bleecker ER
,
Burnette N
,
Carretta EE
,
Couper D
,
Goldin J
,
Guo J
,
Han MK
et al.
. 2016.
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.
.
Am J Respir Crit Care Med. 194(7):794-806.
PubMed
